Conjugated estrogens Intravenous and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Conjugated estrogens Intravenous and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conjugated estrogens
Brand name: Enjuvia, Premarin, Premarin Intravenous, Cenestin
Synonyms: Conjugated estrogens (Intravenous), Estrogens (Conjugated A/Synthetic), Conjugated estrogens
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conjugated estrogens Intravenous-Zoladex 3-Month
- Conjugated estrogens Intravenous-Zoladex Implant
- Conjugated estrogens Intravenous-Zolate
- Conjugated estrogens Intravenous-Zoledronic acid
- Conjugated estrogens Intravenous-Zoledronic Acid (Bone Health)
- Conjugated estrogens Intravenous-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Conjugated estrogens synthetic a
- Zoladex (Goserelin Implant 3.6 mg)-Conjugated estrogens synthetic b
- Zoladex (Goserelin Implant 3.6 mg)-Conjugated Estrogens Tablets
- Zoladex (Goserelin Implant 3.6 mg)-Conjugated estrogens vaginal
- Zoladex (Goserelin Implant 3.6 mg)-Conray
- Zoladex (Goserelin Implant 3.6 mg)-Conray 30